The liver and kidney are linked through many intrinsic pathways. As such, EASL International Liver Foundation and the European Renal Association - European Dialysis and Transplant Association are linking together to jointly tackle key issues. This first meeting will provide an innovative and interactive program addressing two emerging epidemics that have great impact on both the kidney and liver: viral hepatitis and non-alcoholic fatty liver disease (NAFLD).
- Updating on the epidemiology, prevention and clinical consequences of HCV infections in various CKD populations.
- Optimizing new treatments for HCV in the clinical management of CKD patients.
- Understanding the complex links of NAFLD and CKD.
- Moving from established therapies for NAFLD and associated- CKD (especially diabetic nephropathy) to new, emerging ones.
More information on registration, go to website.
EASL International Liver Foundation
European Renal Association - European Dialysis and Transplant Association